TREA

88081271 - CONTRA-MAB

Follow

Information

  • Trademark
  • 88081271
  • Serial Number
    88081271
  • Registration Number
    6029997
  • Filing Date
    August 16, 2018
    7 years ago
  • Registration Date
    April 07, 2020
    5 years ago
  • Transaction Date
    April 08, 2025
    9 months ago
  • Status Date
    April 07, 2020
    5 years ago
  • Published for Opposition Date
    February 05, 2019
    6 years ago
  • Location Date
    March 03, 2020
    5 years ago
  • First Use Anywhere Date
    September 10, 2019
    6 years ago
  • First Use In Commerce Date
    September 10, 2019
    6 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    NADELMAN, ANDREA
  • Attorney Docket Number
    037840410T01
    Attorney Name
    Andrew D. Skale
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
CONTRA-MAB
Case File Statements
  • GS0051: Genetically engineered proteins for diagnostic purposes; gene therapy and proteins, namely, antibodies and fusion proteins for the treatment of cancer; pharmaceutical substances and preparations namely, genetically engineered proteins for medical diagnostic use; pharmaceutical and biochemical preparations for the treatment of cancer; Biochemicals, namely, engineered proteins for the regulation of human, animal, plant, viral and microbial genes for clinical and medical laboratory use in human and animal therapeutics for the treatment of cancer, DNA diagnostics and bioinformatics for medical diagnostic purposes
Case File Event Statements
  • 8/25/2018 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/20/2018 - 7 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/5/2019 - 6 years ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/3/2018 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/6/2018 - 7 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 12/6/2018 - 7 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/6/2018 - 7 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/6/2018 - 7 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/6/2018 - 7 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/26/2018 - 7 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 1/16/2019 - 7 years ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/5/2019 - 6 years ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/27/2019 - 6 years ago
    15 - SOU EXTENSION 1 FILED Type: EXT1
  • 8/27/2019 - 6 years ago
    16 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 8/29/2019 - 6 years ago
    17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/28/2020 - 5 years ago
    18 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 1/28/2020 - 5 years ago
    20 - USE AMENDMENT FILED Type: IUAF
  • 2/12/2020 - 5 years ago
    19 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 2/20/2020 - 5 years ago
    21 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 3/3/2020 - 5 years ago
    22 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 3/4/2020 - 5 years ago
    23 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 4/7/2020 - 5 years ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/7/2025 - 9 months ago
    26 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 4/2/2019 - 6 years ago
    13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/27/2019 - 6 years ago
    14 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/13/2024 - a year ago
    25 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN